KIDSOrthoPediatrics Corp.
Price
+20%1YEnd-of-day closes, not the intraday tick.
Mostly good, one thing to check: safety
Quality strong, a flag to check, growing in the filings, the market undecided.
Charts
As reported to the SEC, without any scoring.
OrthoPediatrics Corp. (KIDS) reported revenue of $71M in Q2 2026 (quarter ended Jun 30, 2026), up 15% from the same quarter a year earlier. That came with a gross margin of 74% and net loss of $7.2M. For the full year FY2025, revenue was $236M (+15% year on year) and net income −$40M. The next results filing is expected around Oct 27, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Apr 1, 2026On March 31, 2026, OrthoPediatrics Corp. (the “Company”) and its wholly owned domestic subsidiaries, as borrowers (collectively, the “Credit Parties”), entered into a First Amendment (the “Amendment”) to that certain Credit Agreement and Guaranty (the “Term Loan Agreement”) dated August 5, 2024, by and among the …Material agreement entered · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.